Literature DB >> 32310186

Age at Onset of Parkinson's Disease Among Ashkenazi Jewish Patients: Contribution of Environmental Factors, LRRK2 p.G2019S and GBA p.N370S Mutations.

Gilad Yahalom1,2,3,4, Amihai Rigbi5, Simon Israeli-Korn2,3,4,6, Lynne Krohn7,8, Uladzislau Rudakou7,8, Jennifer A Ruskey7,9, Lior Benshimol2, Tal Tsafnat2, Ziv Gan-Or7,8,9, Sharon Hassin-Baer2,3,4,6, Lior Greenbaum4,6,10.   

Abstract

BACKGROUND: Both genetic and environmental factors contribute to Parkinson's disease (PD) risk.
OBJECTIVE: We investigated the potential association of several relevant variables with PD age at onset (AAO), focusing on LRRK2 p.G2019S and GBA p.N370S mutations.
METHODS: Ashkenazi Jewish (AJ) PD patients, screened for LRRK2 and GBA mutations, underwent an interview regarding exposure to the following environmental and lifestyle factors: cigarette smoking, consumption of coffee, tea and alcohol, history of head injury and rural living. Multivariate linear regression (adjusted for sex) was used to examine the association with AAO, and models included LRRK2 and GBA mutation status (carrier/non-carriers), single environmental variable and their interactions terms, as independent variables.
RESULTS: 225 Israeli AJ PD patients were enrolled: 65 LRRK2 p.G2019S mutation carriers, 60 GBA p.N370S carriers and 100 non-carries of both mutations. In the dichotomized exposure/non-exposure analyses, positive LRRK2 p.G2019S status was associated with younger AAO in all models, at nominal or near significant levels (p = 0.033-0.082). Cigarette smoking was associated with older AAO (p = 0.032), and the interaction between GBA p.N370S and history of head injury was associated with younger AAO (p = 0.049), both at nominal significance. There was no indication of a consistent main effect for GBA p.N370S status or significant LRRK2 p.G2019S-environmental factor interaction. In the dose-dependent analysis, increased coffee and tea consumption levels were associated with older AAO (p = 0.001 and p = 0.002, respectively).
CONCLUSIONS: Our results suggest that both genetic and environmental factors may affect AAO in PD patients, but validation in additional samples is required.

Entities:  

Keywords:  GBA p.N370S; LRRK2 p.G2019S; Parkinson’s disease; age at onset; caffeine; environmental factors; gene-environment interaction; head injury; lifestyle habits; smoking; tea

Year:  2020        PMID: 32310186     DOI: 10.3233/JPD-191829

Source DB:  PubMed          Journal:  J Parkinsons Dis        ISSN: 1877-7171            Impact factor:   5.568


  5 in total

1.  Nonsteroidal Anti-inflammatory Use and LRRK2 Parkinson's Disease Penetrance.

Authors:  Marta San Luciano; Caroline M Tanner; Cheryl Meng; Connie Marras; Samuel M Goldman; Anthony E Lang; Eduardo Tolosa; Birgitt Schüle; J William Langston; Alexis Brice; Jean-Christophe Corvol; Stefano Goldwurm; Christine Klein; Simone Brockman; Daniela Berg; Kathrin Brockmann; Joachim J Ferreira; Meriem Tazir; George D Mellick; Carolyn M Sue; Kazuko Hasegawa; Eng King Tan; Susan Bressman; Rachel Saunders-Pullman
Journal:  Mov Disord       Date:  2020-07-14       Impact factor: 10.338

Review 2.  Do caffeine and more selective adenosine A2A receptor antagonists protect against dopaminergic neurodegeneration in Parkinson's disease?

Authors:  Jiang-Fan Chen; Michael A Schwarzschild
Journal:  Parkinsonism Relat Disord       Date:  2020-12-19       Impact factor: 4.891

3.  Patients with Autoimmune Hepatitis Report Lower Lifetime Coffee Consumption.

Authors:  Craig Lammert; Sai N Chalasani; Kelsey Green; Elizabeth Atkinson; Bryan McCauley; Konstantinos N Lazaridis
Journal:  Dig Dis Sci       Date:  2021-04-30       Impact factor: 3.487

Review 4.  The Pharmacological Potential of Adenosine A2A Receptor Antagonists for Treating Parkinson's Disease.

Authors:  Akihisa Mori; Jiang-Fan Chen; Shinichi Uchida; Cecile Durlach; Shelby M King; Peter Jenner
Journal:  Molecules       Date:  2022-04-06       Impact factor: 4.411

5.  Age at onset as stratifier in idiopathic Parkinson's disease - effect of ageing and polygenic risk score on clinical phenotypes.

Authors:  L Pavelka; A Rauschenberger; Z Landoulsi; S Pachchek; P May; E Glaab; R Krüger
Journal:  NPJ Parkinsons Dis       Date:  2022-08-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.